Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07019428Recruiting
A new way to stabilize gum grafts with titanium tacs
This trial tests a method using small titanium tacs to hold a gum graft in place instead of stitches. It may help people with thin gum tissue around dental implants have a more comfortable and effective procedure.
CairoAges 18–40 - NCT07013695Recruiting
Virtual reality to reduce sedation in orthopedic surgery
This trial tests if watching virtual reality during regional anesthesia for planned arm or leg surgery can lower the need for calming medicine. It may help you feel more relaxed without as many drugs.
ÉvreuxAges 18 years+ - NCT07013773RecruitingPhase 1
How food affects Y-4 tablets in healthy people
This study tests how food affects the way a new medicine (Y-4 tablet) is processed in the body. It is looking for healthy volunteers to take a single dose of the study drug and have their blood levels checked over time.
Beijing, Beijing MunicipalityAges 18–45 - NCT07017062Recruiting
Study of ceramic veneers bonded with two self-adhesive dental cements
This trial compares two types of self-adhesive resin cements for bonding ceramic occlusal veneers. It aims to see which cement works better for restoring back teeth while keeping your natural tooth structure.
CairoAges 21 years+ - NCT07021404Recruiting
Suicide attempts and thoughts in Flanders
This study looks at how many people come to the emergency department in Flanders after a suicide attempt or with suicidal thoughts. It aims to understand the patterns of these events to help improve care and prevention.
AalstAges 12 years+ - NCT06350032RecruitingPhase 3
Testing treprostinil safety in children with PAH
This trial tests a medicine called treprostinil in children with severe pulmonary arterial hypertension (high blood pressure in the lungs). The study aims to see if it is safe and tolerable for kids who need this kind of therapy.
Vienna, State of ViennaAges Up to 18 years - NCT06653387Recruiting
Testing a new carotid stent with blood-flow reversal for high-risk patients
This trial tests a new carotid stent system used with a special blood-flow reversal device to treat blocked carotid arteries. It is for people with high-risk conditions who might not be good candidates for traditional open surgery, and aims to see if the stent is safe and effective in preventing strokes.
Sacramento, CaliforniaAges 18–79 - NCT07005752RecruitingPhase 4
CnU capsule for cholesterol gallstones
This trial tests if CnU capsules shrink cholesterol gallstones in people who have stones smaller than 15 millimeters. It aims to help people dissolve stones without surgery.
Ansan, Gyeonggi-doAges 19 years+ - NCT07003841Recruiting
AR-guided breast cancer localization trial
This trial tests an augmented reality (AR) tool to help surgeons locate breast cancer tumors during breast-conserving surgery. You may join if you have a single, small invasive breast tumor and have not had chemotherapy before surgery.
Seoul, Gangseo-guAges 19–80 - NCT07005232Enrolling by invitation
OmniaSecure defibrillation lead safety study
This study follows patients who have or will receive the OmniaSecure defibrillation lead to see how well it works and how reliable it is over time. If you have this lead, you may be able to help researchers understand its long-term performance.
Birmingham, AlabamaAges Any age - NCT07003425RecruitingPhase 2
Long-term safety and effectiveness of APG777 for eczema
This study looks at the long-term safety and how well APG777 works for people with eczema (atopic dermatitis). It is for people who have already completed treatment with APG777 in an earlier study and may benefit from continuing it.
Fountain Valley, CaliforniaAges 18 years+ - NCT07008118RecruitingPhase 1
Study of INCA035784 for certain blood cancers
This trial tests a new drug, INCA035784, for people with myeloproliferative neoplasms (MPNs), a group of blood cancers. It may help if your MPN is called myelofibrosis (MF) or essential thrombocythemia (ET) and has a specific genetic change (CALR mutation), and you've already tried other treatments.
Phoenix, ArizonaAges 18 years+ - NCT07005180RecruitingPhase 2
Carbon monoxide gas for Parkinson's disease
This trial tests if a low dose of carbon monoxide (HBI-002) is safe and helpful for people with Parkinson's disease. It requires specific health criteria and stable Parkinson's medication.
Fountain Valley, CaliforniaAges 40–80 - NCT07011732RecruitingPhase 3
Testing a drug for Alzheimer's-related agitation
This study tests an experimental drug (KarXT) to see if it safely reduces agitation in people with Alzheimer's disease. It may help if you or your loved one experiences restlessness, aggression, or irritability related to Alzheimer's.
Scottsdale, ArizonaAges 55–90 - NCT07007962RecruitingPhase 3
Oral pill for immune thrombocytopenia after first treatment fails
This trial tests an oral medicine called rilzabrutinib for adults with immune thrombocytopenia (ITP) whose first treatment stopped working or who need steroids long-term. The goal is to see if it helps raise platelet counts and reduce bleeding risk.
Clovis, CaliforniaAges 18 years+ - NCT07009171RecruitingPhase 2
Testing KDS2010 for weight loss in overweight or obese adults
This study tests a new medication called KDS2010 for people who are overweight or have obesity. The goal is to see if it helps with weight loss when combined with diet and exercise.
Suwon, Gyeonggi-doAges 18 years+ - NCT07009236Recruiting
MINIject S+ for open angle glaucoma
This trial tests a tiny implant called MINIject S+ to lower eye pressure in people with open angle glaucoma that isn't well controlled with eye drops. It may be done alone or with cataract surgery.
Santa Rosa de CopánAges 20 years+ - NCT07010354Recruiting
BeFlow Stent Study for Iliac Artery Blockages
This study is testing a new stent called BeFlow to see how well it works and how safe it is for people with blocked or narrowed iliac arteries. The stent is placed permanently to keep the artery open.
AalstAges 18 years+ - NCT07012291Recruiting
Blood test for patients on blood thinners
This study tests a new blood test called ClotChek™ to see how well it works for people taking direct oral anticoagulants (DOACs), a type of blood thinner. You would give a blood sample, and the test may help doctors better monitor your medication.
Danbury, ConnecticutAges 18–80 - NCT07013097RecruitingPhase 1
Testing PG-033 in healthy adults: a first-in-human study
This trial tests a single dose of a new medicine called PG-033 in healthy adults. It checks how the drug moves through the body and how food affects it, to find the safest starting dose for future studies.
Beijing, Beijing MunicipalityAges 18–45 - NCT07011745RecruitingPhase 3
Study of KarXT for Alzheimer's Agitation
This study tests a new drug combination (KarXT + KarX-EC) to see if it can safely reduce agitation in people with Alzheimer's disease. It may help if you or your loved one has bothersome agitation that affects daily life.
Chandler, ArizonaAges 55–90 - NCT07007637Enrolling by invitationPhase 3
Long-Term Safety and Effectiveness of Sonelokimab for Hidradenitis Suppurativa
This study offers long-term treatment with an investigational biologic, sonelokimab, for people with moderate to severe hidradenitis suppurativa who finished an earlier sonelokimab study. The goal is to see if sonelokimab remains safe and effective over time.
Birmingham, AlabamaAges 12 years+ - NCT07005154RecruitingPhase 2
Study of ASP5541 for metastatic prostate cancer
This study tests an experimental drug called ASP5541 for men with metastatic prostate cancer (either hormone-sensitive or castration-resistant). It aims to see if the drug can slow cancer growth and improve outcomes when added to standard hormone therapy.
Huntsville, AlabamaAges 18 years+ - NCT07005713RecruitingPhase 1
Study of tacabrutideg for chronic spontaneous urticaria
This trial tests a new oral medication called tacabrutideg (BGB-16673) for chronic spontaneous urticaria, a condition with frequent hives and itching. It aims to see how safe it is and how well it works, possibly offering a new option for people who still have symptoms despite antihistamines.
Beijing, Beijing MunicipalityAges 18–70
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.